Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.

Terbinafine is more effective than itraconazole for toenail fungus, especially in older patients, and debridement improves its effectiveness.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Some gonadal hormone drugs can block filovirus entry into cells.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Tribulus terrestris may protect the liver from drug damage.

Itraconazole helps improve tough skin infections but may not prevent them from coming back.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

Long-term use of calcineurin inhibitors in transplant patients can cause hormone issues that can be managed with proper care.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Vitamin D protects skin cells from damage caused by captopril.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.